BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9669187)

  • 1. Long-term outcome with clozapine: comparison of patients continuing and discontinuing treatment.
    Laker MK; Duffett RS; Cookson JC
    Int Clin Psychopharmacol; 1998 Mar; 13(2):75-8. PubMed ID: 9669187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
    Nyakyoma K; Morriss R
    Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system.
    Reid WH; Mason M
    J Clin Psychiatry; 1998 Apr; 59(4):189-94. PubMed ID: 9590670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine as a first treatment for schizophrenia.
    Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
    Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
    Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
    J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
    Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
    Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of clozapine use for psychosis in parkinsonian patients.
    Fernandez HH; Donnelly EM; Friedman JH
    Mov Disord; 2004 Jul; 19(7):831-833. PubMed ID: 15254945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.
    Ciapparelli A; Dell'Osso L; Pini S; Chiavacci MC; Fenzi M; Cassano GB
    J Clin Psychiatry; 2000 May; 61(5):329-34. PubMed ID: 10847306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine treatment in a population of adults with mental retardation.
    Antonacci DJ; de Groot CM
    J Clin Psychiatry; 2000 Jan; 61(1):22-5. PubMed ID: 10695641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful rechallenge with clozapine following 'red alert'.
    Toni-Uebari TK; Rees J
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23345473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital.
    Wilson WH; Claussen AM
    Psychiatr Serv; 1995 Apr; 46(4):386-9. PubMed ID: 7788462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
    Conley RR; Love RC; Kelly DL; Bartko JJ
    Am J Psychiatry; 1999 Jun; 156(6):863-8. PubMed ID: 10360124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine: acquittal of the usual suspect.
    Schmitz-Hübsch T; Schlaepfer TE; Westheide J; von Falkenhausen M; Cooper-Mahkorn D; Maier W; Kühn KU
    World J Biol Psychiatry; 2009; 10(4 Pt 3):981-4. PubMed ID: 19711227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.
    Chengappa KN; Ebeling T; Kang JS; Levine J; Parepally H
    J Clin Psychiatry; 1999 Jul; 60(7):477-84. PubMed ID: 10453803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and recidivism.
    Gordon BJ; Milke DJ
    Psychiatr Serv; 1995 Oct; 46(10):1079. PubMed ID: 8829795
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of clozapine in 10 mentally retarded adults.
    Buzan RD; Dubovsky SL; Firestone D; Dal Pozzo E
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):93-5. PubMed ID: 9547472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of tardive syndromes with clozapine: a case series.
    Grover S; Hazari N; Kate N; Chakraborty K; Sharma A; Singh D; Gupta J; Lahariya S
    Asian J Psychiatr; 2014 Apr; 8():111-4. PubMed ID: 24655641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine in Parkinson's disease psychosis: 5-year follow-up review.
    Klein C; Gordon J; Pollak L; Rabey JM
    Clin Neuropharmacol; 2003; 26(1):8-11. PubMed ID: 12567158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.